Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

CDRH report highlights scientific activities that support medical device industry

The U.S. Food and Drug Administration's Center for Devices and Radiological Health (CDRH) today released a report highlighting scientific activities that support the medical device industry and product development, while maintaining the safety and effectiveness of the products.

4 Oct 2011

Drug shortages lead to rationing of critical medicines

Though a number of reasons have created the shortfalls, everyone agrees that the proliferation of "gray markets" is one of the biggest factors.

3 Oct 2011

Emergent BioSolutions receives $1.25B contract to supply 44.75M doses of BioThrax

Emergent BioSolutions Inc. today announced that, in response to solicitation RFP-2011-N-13414, it has received an award to supply the U.S. government with 44.75 million doses of BioThrax (Anthrax Vaccine Adsorbed) over a period of five years for a total value of up to $1.25 billion.

3 Oct 2011

CSL pays heed to FDA observations on faulty manufacturing processes

Australia’s biggest pharmaceutical company CSL has taken steps to address most manufacturing flaws highlighted by the US Food and Drug Administration (FDA) and promised that the remaining concerns are being resolved.

2 Oct 2011

Smoking worst among miners, hoteliers and construction workers: CDC report

A new Centers for Disease Control and Prevention (CDC) report reveals that miners, construction workers and people in the hotel and food service industry have the highest smoking rates, while those in education have the lowest.

2 Oct 2011

Roche inaugurates new clinical supply manufacturing facility in Nutley, N.J.

Roche announced today the opening of a new state-of-the-art clinical supply manufacturing facility on its campus in Nutley, N.J. The Roche Center of Excellence produces dosage forms of highly potent compounds for preclinical safety studies, and Phase 1 and 2 clinical studies.

30 Sep 2011

Two ACS members, editor of JACS to receive nation's highest honors in science and innovation

Peter J. Stang, Ph.D., editor of the Journal of the American Chemical Society (JACS), and American Chemical Society members Jacqueline K. Barton, Ph.D. and Rakesh Agrawal, Ph.D., are among 12 eminent researchers and inventors named by President Obama to receive the nation's highest honors in science and innovation.

30 Sep 2011

Study highlights importance of prior planning before introduction of new vaccines

Proper planning before the introduction of new vaccines into a developing country's active immunization program could prevent storage problems and transportation bottlenecks that decrease the availability of existing vaccines by as much as two-thirds, according to a University of Pittsburgh study.

30 Sep 2011

Circadian files IND with FDA for VGX-100 for the treatment of cancer patients with solid tumors

Circadian Technologies Limited (ASX: CIR, OTCQX:CKDXY) is extremely proud to announce that its 100% owned subsidiary, Vegenics Pty Ltd, has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) to initiate clinical studies of VGX-100. The first trial (Phase I) will involve the treatment of a variety of different cancer types in patients with late stage cancer.

29 Sep 2011

Poor hospital supplies could spell danger for vulnerable patients

It was found that most hospitals operate with less than a month's supply of many essential medicines, leaving patients vulnerable if local distributors are unable to import them through fragile international supply chains.

29 Sep 2011

Tobacco companies deliberately kept findings of cancer-causing radioactive particles from the public

Tobacco companies knew that cigarette smoke contained radioactive alpha particles for more than four decades and developed "deep and intimate" knowledge of these particles' cancer-causing potential, but they deliberately kept their findings from the public, according to a new study by UCLA researchers.

29 Sep 2011

TD2 wins AZBio's Fast Lane award for economic development of Arizona biosciences

TGen Drug Development (TD2) won a Fast Lane award from the Arizona BioIndustry Association (AZBio) for promoting the economic development of Arizona biosciences.

29 Sep 2011

Merck sells 50% interest in JJMCP joint venture

Merck, known outside the United States and Canada as MSD, today announced that the company has sold its 50 percent interest in the Johnson & Johnson--Merck Consumer Pharmaceuticals Co. joint venture (JJMCP) to Johnson & Johnson (J&J) affiliates, McNEIL-PPC, Inc., McNEIL MMP, LLC, and Johnson & Johnson, Inc.

29 Sep 2011

U of A researchers discover active environmental catalyst

University of Alberta chemistry researchers have discovered an active catalyst that has the potential to improve the efficiency and environmental impact of manufacturing processes used to make products such as agrochemicals and pharmaceuticals.

28 Sep 2011

Photocure, Ipsen partner to commercialise Hexvix for diagnosis of bladder cancer

Ipsen announces today a partnership with Photocure, a specialty pharmaceutical company focused on photodynamic technologies in cancer and dermatology.

27 Sep 2011

TPI revenue increases 48.9% to $95.2 million for fiscal year 2011

Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals, announced the financial results for the Fiscal Year 2011.

27 Sep 2011

Vaxent, PREVENT sign license agreement to develop and commercialize Strep-A vaccine

An international collaboration between Vaxent, a Memphis-based early stage vaccine development company in the Memphis Bioworks Foundation Incubator, and The Pan-Provincial Vaccine Enterprise Inc. (PREVENT), a Centre of Excellence for Commercialization and Research (CECR) in Saskatchewan, has put a vaccine for group A streptococcus (Strep-A) back on the path for potential commercialization.

26 Sep 2011

U-M receives $2.2M FDA grant for 40 ongoing pediatric device projects

Adapting adult medical devices to be used for children is a common but often problematic practice across U.S. hospitals. At the University of Michigan and U-M C.S. Mott Children's Hospital, pediatricians and researchers who care for children have been leading the charge to change this. They work to create, engineer and test medical devices and curb problems that come from using tools, implants, gadgets and procedures designed for adults.

26 Sep 2011

Corgenix fiscal 2011 net sales decrease to $7,941,576

Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, today filed its fiscal year Form 10-K and reported financial results.

23 Sep 2011

YM BioSciences total revenue decreases to $1.5 million for fiscal 2011

YM BioSciences Inc., a drug development company advancing a diverse portfolio of promising hematology and cancer-related products, today reported operational and financial results for its 2011 fiscal year, ended June 30, 2011.

23 Sep 2011

Manufacturing News and Research

Further Reading

CDRH report highlights scientific activities that support medical device industry

Drug shortages lead to rationing of critical medicines

Emergent BioSolutions receives $1.25B contract to supply 44.75M doses of BioThrax

CSL pays heed to FDA observations on faulty manufacturing processes

Smoking worst among miners, hoteliers and construction workers: CDC report

Roche inaugurates new clinical supply manufacturing facility in Nutley, N.J.

Two ACS members, editor of JACS to receive nation's highest honors in science and innovation

Study highlights importance of prior planning before introduction of new vaccines

Circadian files IND with FDA for VGX-100 for the treatment of cancer patients with solid tumors

Poor hospital supplies could spell danger for vulnerable patients

Tobacco companies deliberately kept findings of cancer-causing radioactive particles from the public

TD2 wins AZBio's Fast Lane award for economic development of Arizona biosciences

Merck sells 50% interest in JJMCP joint venture

U of A researchers discover active environmental catalyst

Photocure, Ipsen partner to commercialise Hexvix for diagnosis of bladder cancer

TPI revenue increases 48.9% to $95.2 million for fiscal year 2011

Vaxent, PREVENT sign license agreement to develop and commercialize Strep-A vaccine

U-M receives $2.2M FDA grant for 40 ongoing pediatric device projects

Corgenix fiscal 2011 net sales decrease to $7,941,576

YM BioSciences total revenue decreases to $1.5 million for fiscal 2011

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest Life Science News